ALB and plasma cell myeloma: Using multiple myeloma (MM) and metastatic breast cancer models in mice, we demonstrate that incorporating unmodified and pristine hydrophobic light-sensitive drugs in tumour-targeted lipid nanomicelles or human serum albumin (HSA) nanoparticles, selectively deliver the agents in disseminated cancer cells.